Brief: CanSino Biologics Signs Product Supply Framework Agreement With Astrazeneca
08/08/2023 10:11
Aug 8 (Reuters) - CanSino Biologics Inc 688185.SS :
* SAYS IT SIGNS PRODUCT SUPPLY FRAMEWORK AGREEMENT WITH
ASTRAZENECA AB FOR MRNA VACCINE PROJECT
Source text
Further company coverage: 688185.SS
(Reporting by Hong Kong Newsroom)
((Ethan.Wang@thomsonreuters.com;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025